Abstract The Myc transcription factor is commonly dysregulated in many human cancers, including breast carcinomas. However, the precise role of Myc in the initiation and maintenance of malignancy is unclear. In this study we compared the ability of wild-type Myc (wt Myc) or Myc phosphorylation deficient mutants (T58A, S62A or T58A/S62A) to immortalize and transform human mammary epithelial cells (HMECs). All Myc constructs promoted cellular immortalization. As previously reported in other cells, the Myc T58A mutant tempered apoptotic responses and increased Myc protein stability in HMEC cells. More importantly, we now show that HMECs overexpressing the Myc T58A mutant acquire a unique cellular phenotype characterized by cell aggregation, detachment from the substrate and growth in liquid suspension.
Introduction
Cellular immortalization is a critical step in the oncogenic progression of a normal cell [1] . In order for cells to become immortalized, they first must bypass cellular senescence, which is a non-replicative state reached by cells following a finite number of divisions [2, 3] . Cultured human mammary epithelial cells (HMECs) undergo senescence in two distinct stages [4] [5] [6] . The first stage has recently been termed stasis [7] , although it also is referred to as senescence or selection. While most cells cease proliferating at this point, a subpopulation can bypass stasis and continue to grow [4] [5] [6] . These HMECs are characterized by a loss of p16 INK4A expression caused by promoter methylation [5, 8, 9] and are referred to as post-selection HMECs. Post-selection HMECs divide until they reach agonescence, a state characterized by shortened telomeres, genomic instability and senescent phenotypes [6, 10] .
Although no post-selection HMECs have been reported to bypass agonescence spontaneously [11] , the addition of a single oncogene can allow growth past this barrier, thus leading to HMEC immortalization. Examples of such oncogenes include the human papillomavirus E6 gene [12] , human telomerase reverse transcriptase (hTERT) [13] , the zinc-finger protein ZNF217 [14] , the transcription repressor Bmi-1 [15] and the transcription factor Myc [16] . In addition to immortalization, another key characteristic of oncogenic cells is the capability for anchorage-independent growth [1] . In general, many immortalized HMEC lines lack this capability [12, 15, 17] . Several groups, however, have generated fully-transformed HMECs using two or more oncogenes [17] [18] [19] [20] [21] [22] . Interestingly, limited evidence exists that overexpression of a single gene, Wnt-1, can lead to HMEC transformation [23] .
The Myc oncogene is overexpressed in many types of human cancer, including breast carcinomas [24] . Myc is a transcription factor involved in the regulation of a wide variety of cellular genes, including those that modulate the cell cycle, protein synthesis, cellular adhesion, metabolism and apoptosis [25, 26] . The N-terminus of Myc contains the transactivation domain (TAD), which is involved in the induction of Myc target genes [27] . The TAD contains several phosphorylation sites, including threonine-58 (T58) and serine-62 (S62) [28] [29] [30] , and the area surrounding T58 constitutes a mutational hotspot in Burkitt's lymphomas (BLs) [31, 32] . In addition, the specific mutation of threonine-58 to alanine (T58A) is found in some BL cell lines [31] [32] [33] .
The T58 and S62 sites have been implicated in regulating several biological properties of Myc, including protein stability, apoptosis and cellular transformation. Mitogenic stimulation or signaling through the Ras pathway increases both phosphorylation at S62 and Myc protein stability in cells [34] [35] [36] . In contrast, the half-life of the Myc serine-62 to alanine point mutant (S62A) is less than that of wild-type (wt) Myc and cannot be increased by activated Ras [36] . Glycogen synthase kinase-3 (GSK3) phosphorylates Myc at T58 [34, 37] , which only occurs following prior phosphorylation at S62 [34, 36] . Phosphorylation at T58 leads to dephosphorylation at S62 and decreases Myc stability, whereas the T58A point mutation increases the protein halflife [36] [37] [38] . A single phosphorylation event at T58 acts as a signal for Myc ubiquitination, marking the protein for destruction by the proteasome [39] .
Point mutations at T58 and S62 also can modulate Myc's ability to promote apoptosis and transformation. In rodent fibroblast systems, serum starvation conditions lead to a higher rate of apoptosis in cells overexpressing wt Myc compared to cells overexpressing Myc T58A [33, 40] . Myc S62A, on the other hand, induces apoptosis at a rate comparable to the wt protein [33] . In addition to attenuating apoptotic responses, Myc T58A has been shown to enhance cellular transformation in tissue culture systems. For example, Myc T58A induces greater anchorageindependent growth than wt Myc when co-expressed with Ras in rodent cells [30, 33] . However, transfections with Ras and Myc S62A resulted in decreased anchorage-independent growth. The T58A, but not the S62A, point mutation also has been shown to increase the transforming ability of Myc in conjunction with additional oncogenes in human embryonic kidney cells and BJ fibroblasts [41] . Finally, a mouse model of Burkitt's lymphoma has shown Myc T58A to be more oncogenic than wt Myc [42] .
The existing data in the literature pertaining to Myc immortalization of post-selection HMECs are limited [16] , and it has been suggested that such immortalization is a rare event [11] . Even more importantly, there are no studies on the effect of Myc phosphorylation deficient mutant proteins on human breast cell immortalization or transformation. DNA sequencing of breast tumor samples and cancer cell lines has failed to uncover point mutations at either T58 or S62 ( [43] and our unpublished data). However, point mutations are not the only way to modulate Myc phosphorylation. Aberrant Ras or GSK3 signaling in breast cancer may mimic the effects of the Myc phosphorylation deficient mutants, as these are the pathways involved in phosphorylation at S62 and T58, respectively [34] [35] [36] [37] . In addition, Rodrik et al. found that in the MCF-7 breast cancer cell line both estrogen and phospholipase D (PLD) decreased Myc phosphorylation at T58 [44] , thus having a similar effect as a T58A point mutation. Therefore, investigating Myc phosphorylation in HMECs may lead to important insight into the onset and development of breast cancer.
In this study, we demonstrate that wt Myc and Myc phosphorylation deficient mutants can immortalize breast cells and that this does not appear to be a rare event. More importantly, cells immortalized by the tumor-derived Myc T58A mutant spontaneously underwent a unique morphological change coupled with anchorage-independent growth. Myc T58A cells also demonstrated a reduced sensitivity to apoptotic stimuli and the anticipated increase in Myc protein half-life. Finally, we have identified changes in gene expression that correlate with the acquisition of anchorage-independent growth. 
Materials and methods

Cell
Retroviruses and retroviral-mediated gene transfer
Post-selection and hTERT-immortalized HMECs were transduced with amphotropic LXSN empty vector and cDNA-containing retroviruses constructs for wt Myc, Myc T58A, Myc S62A, Myc T58A/S62A or HPV E6. Amphotropic empty vector pBabe-puro or pBabe-puro-hTERT constructs, which were generously provided by Dr. Robert A. Weinberg [45] , also were used for transduction. Retroviruses were produced and HMECs were transduced as previously described [46] [47] [48] . Transduced cells were positively selected in 100 lg/ml G418 (Invitrogen, Carlsbad, CA) or 0.5 lg/ml puromycin (Calbiochem, San Diego, CA) as appropriate for 10 days.
Apoptosis assays
T-75 tissue culture flasks were seeded with 1.5 9 10 6 wt Myc or Myc T58A HMECs. The following day, the flasks were subjected to 24 Gy of ionizing radiation using a 137 Cs source c-irradiator (JL Shepherd, San Fernando, CA) to induce apoptosis. Samples were rotated during irradiation. 
Western blot analysis
Cell lysates were prepared and loaded onto 4-20% gradient Tris-glycine gels (Invitrogen, Carlsbad, CA), and gel electrophoresis and PVDF membrane transfer were performed as previously described [49] . Membranes were probed with antibodies against T58 or T58/S62 phospho-Myc (9401, Cell Signaling Technology, Danvers, MA) or total Myc (sc-40, Santa Cruz Biotechnology, Santa Cruz, CA) at 1:1,000. Membranes were probed with secondary antibodies conjugated to alkaline phosphatase (Sigma-Aldrich, St. Louis, MO) at 1:1,000 and detected with CDP-Star chemiluminescent substrate (Sigma-Aldrich, St. Louis, MO). As a loading control, membranes were probed with an antibody against b-actin (Sigma-Aldrich, St. Louis, MO) at 1:10,000. Membranes were stripped after each primary antibody detection using Restore Western Blot Stripping Buffer (Pierce, Rockford, IL).
Soft agar assays and images
Immortalized HMECs and HeLa cells were tested for growth in soft agar in 6-well tissue culture plates (2 9 10 3 cells per well) or 60 mm tissue culture dishes (1 9 10 4 cells per dish) with appropriate media as previously described [50] . Colonies were allowed to form for 2-4 weeks, during which time fresh media was added to the plates once a week. All experiments were done in triplicate. Colonies in 60 mm dishes were stained with 2 ml 0.005% crystal violet (SigmaAldrich, St. Louis, MO) and washed 3 times with dH 2 O for destaining. Colony images were visualized with a Zeiss Axiovert 10 microscope (Carl Zeiss, Inc., Thornwood, NY), and digital phase-contrast micrographs were captured using an InSight camera and Spot Advanced software (Diagnostic Instruments, Inc., Sterling Heights, MI). Digital 19 photographs of 6-well plates were captured using a Kodak DC290 digital camera and Kodak Molecular Imaging software (Eastman Kodak Company, Rochester, NY). Digital 19 images of stained 60 mm dishes were obtained and colony counts were performed using BioRad Quantity One imaging system and software (Bio-Rad Laboratories, Hercules, CA).
Microarray analysis
Four microarray assays were performed, representing two biological repeats, each with two technical repeats, to compare gene expression changes in Myc T58A HMECs at preand post-anchorage-independent growth timepoints. Total RNA was harvested from HMECs using the RNAqueous-4PCR kit (Ambion, Inc., Austin, TX) per manufacturer's protocol and sent to MOgene, LC (St, Louis, MO) for microarray analysis using a two-color Agilent Whole Human Genome slide with 4 9 44K format. Results from the microarray analysis were provided to the Bioinformatics and Biostatistics Shared Resource at the Georgetown University Lombardi Comprehensive Cancer Center (Washington, DC) for statistical analysis. Data was derived from the digital array image using Feature Extraction Software (Agilent Technologies, Santa Clara, CA). The data was normalized for variations in the intensities of the dyes by applying the Lowess model to localized subsets of the data across the entire array. Following normalization, all data were included in subsequent analyses; no minimum intensity cutoff was used to filter the data. Averages were calculated for each gene intensity across the four arrays, and fold change calculations were made based on these averages. Marray software and linear models for microarray data (limma) analysis and software [51] (both are BioConductor opensource packages, http://www.bioconductor.org) were used to generate P-values.
Results
All Myc constructs immortalize post-selection HMECs
In order to determine the relative efficiency of Myc immortalization, retroviral transductions of post-selection HMECs were performed. Cells were transduced with either wt Myc or Myc phosphorylation deficient mutants: Myc T58A, Myc S62A or Myc T58A/S62A. LXSN and p-Babe-puro empty vectors were used as negative immortalization controls, while p-Babe-hTERT or LXSN-HPV E6 was used as a positive control. As anticipated from earlier studies, either hTERT or E6 alone was sufficient to immortalize HMECs [12, 13] . Interestingly, all Myc constructs were capable of immortalizing HMECs in two separate transductions using cells from two independent donors (Fig. 1) . However, one donor showed a lag in initial growth in lines overexpressing wt Myc compared to the Myc mutants (Fig. 1a) . The growth lag was observed when the empty vector controls ceased proliferation. No such growth lag was seen in two experiments with a second donor (Fig. 1b) . These results suggest there may be donorspecific events that regulate the ability of wt Myc to efficiently immortalize HMECs. Regardless of the variation of wt Myc immortalization efficiency, our data indicate for the first time that phosphorylation deficient Myc mutants reproducibly immortalize HMECs with similar efficiency. Cells from the immortalization experiment depicted in Fig. 1a were used in all subsequent experiments.
The T58A mutation reduces Myc-induced apoptosis in HMECs Previous studies indicate that the T58A mutation impairs the apoptotic potential of Myc in rodent cells [33, 40, 42] . We further evaluated the apoptotic potentials of immortalized wt Myc and Myc T58A to determine if the mutation has a similar effect in HMECs. Ionizing radiation was used to induce apoptosis in HMECs, and following irradiation, the cells were fixed and stained with propidium iodide to measure DNA content. The percentage of apoptotic cells seen 72 h following 24 Gy of ionizing radiation was higher in wt Myc HMECs than Myc T58A HMECs, as indicated by the sub-G1 DNA content population measured by flow cytometry (Fig. 2a) . Representative histograms of DNA content in the irradiated cells are shown in Fig. 2b .
The Myc T58A point mutation stabilizes Myc protein in HMECs
The Myc T58A mutation previously has been shown to also increase protein stability in rodent cells and cancer cells lines [36] [37] [38] . However, there is no data demonstrating this alteration of stability in HMECs. To address this question, we conducted pulse-chase experiments using asynchronously growing populations of immortalized wt Myc or Myc T58A HMEC lines. Following a 1 h pulse with 35 S to radioactively label cellular proteins, cells were chased with cold media and lysed at various timepoints. These lysates then were immunoprecipitated with Myc antibody to allow for specific protein detection. As seen in Fig. 3a , labeled Myc protein was detected over a longer time course in cells with the Myc T58A mutant. Linear regression analysis was performed on results from three independent experiments to calculate a half-life for Myc protein in both cell lines. As seen in Fig. 3b , the Myc half-life was significantly longer in Myc T58A HMECs compared to wt Myc HMECs, 25.7 min vs. 14.6 min. Therefore, T58A acts as a Myc stabilizing mutation in the HMEC system.
The increased half-life of Myc T58A did not result in an appreciable increase in total Myc protein, similar to previously published reports [28, 33, 34, 40] . Western blots were performed on the immortalized HMEC cell lines to evaluate the expression and phosphorylation of the Myc protein (Fig. 3c) . All of the Myc-transduced cells expressed similar amounts of Myc protein, and these levels were significantly higher than those observed in either the LXSN-transduced cells or the hTERT-immortalized cells. Indeed, Myc expression in the Myc-immortalized cells was equivalent to the highly oncogenic HeLa cell line. As anticipated, despite overexpression, the Myc protein in cell lines expressing a phosphorylation deficient mutant was only weakly reactive with a phosphorylation-specific Myc antibody. In contrast, the Myc protein expressed in the wt Myc HMECs or the HeLa cells reacted more strongly with this antibody. HMECs expressing Myc T58A undergo morphologic changes during cell passaging
The phase-contrast micrographs in the top panel of Fig. 4 represent the Myc-transduced HMEC lines following successful transit through agonescence. After approximately 35-40 additional passages beyond agonescence, the Myc T58A HMECs grew in clusters that rounded up and detached from the tissue culture substrate (Fig. 4, bottom  panel) . The detached clusters (inset) were not apoptotic but rather remained viable and could be replated and cultured further (data not shown). The Myc T58A HMECs were carried beyond the fully immortal state several times, and the described phenotype was observed each time. This dramatic morphological change was not observed with the other phosphorylation deficient Myc mutants. Both the Myc S62A line and the Myc T58A/S62A line retained their cuboidal shape and substrate attachment after the same number of additional passages (Fig. 4, bottom panel) .
Wild-type Myc, on the other hand, mediated a different morphological change, in which cells assumed a more fibroblast-like appearance with cellular extensions (Fig. 4 , bottom panel). Despite this morphological alteration, the cells retained their substrate attachment. Interestingly, a previous report has described a similar fibroblastic morphological conversion following wt Myc overexpression in an hTERT-immortalized HMEC line [18] .
Myc T58A-immortalized HMECs form colonies in soft agar
Most immortalized HMEC lines are incapable of anchorage-independent growth [12, 15, 17] . However, due to the unique and undescribed growth and morphological alterations that we observed with Myc T58A cells, we screened the various immortalized HMECs for their ability to grow in soft agar. To our surprise, we found that Myc T58A HMECs proliferated and formed colonies in soft agar, whereas HMECs immortalized by the other Myc mutants did not (Fig. 5a ). HMECs overexpressing wt Myc showed limited growth in agarose. Importantly, the colonies formed by Myc T58A HMECs were larger and more numerous than those formed by the wt Myc HMECs, with some comparable in size to those formed by highly transformed HeLa cells. As anticipated, HMECs immortalized by hTERT were unable to form colonies [17] (Fig. 5a) . The onset of anchorage-independent growth for both wt Myc and Myc T58A HMECs correlated temporally with the changes in cell morphology shown in Fig. 4 ; prior to these morphological changes, the Myc T58A HMECs did not form colonies in agarose (data not shown). Independent experiments with later passage cells were used to confirm these altered growth properties and to quantify growth in agarose (Fig. 5b) . Again, Myc T58A formed more colonies and larger colonies than those generated by wt Myc.
Myc T58A and wt Myc can also induce anchorageindependent growth in previously immortalized HMECs
A recent study has shown that wt Myc can induce hTERTimmortalized HMECs to proliferate in agarose, suggesting a direct role for Myc in anchorage-independent cell growth [18] . To determine if the biological activities that we have measured in Myc-immortalized cells also can be observed in cells that have been immortalized with an oncogene other than Myc, we performed the following experiment. hTERT-immortalized HMECs were transduced with LXSN empty vector, wt Myc or Myc T58A retroviruses and then assayed for growth in agarose. Confirming the previous study [18] , wt Myc was able to induce growth of hTERT HMECs in soft agar (Fig. 6 ). More interestingly, as shown in Fig. 6 , Myc T58A induced more frequent and much larger colonies than wt Myc in hTERT HMECs. The LXSN control vector showed only background colony formation. These experiments further indicate that the Myc T58A mutant is a stronger inducer of anchorage-independent growth than wt Myc, and this phenomenon is not related to the immortalization process.
HMEC gene expression during the transition to anchorage-independent growth
As stated previously, the Myc T58A-immortalized HMEC line evolved from anchorage-dependence to anchorageindependence following continued passaging in vitro. These cells, therefore, may serve as a model system for investigating the progression of breast epithelial cells to a transformed state. To examine changes in gene transcription during this progression, we harvested total RNA from Myc T58A HMECs prior to and after their conversion to anchorage-independent growth. Microarray assays then were performed using the Agilent Whole Human Genome two-color system to compare changes in gene expression.
No minimum cutoff was used to filter the data generated from the microarrays. A subset of 149 genes with an absolute fold change of five or greater and a P-value less than 0.05 were identified following statistical analysis using marray and linear models for microarray data (limma) analysis and software. Table 1 lists the 95 genes downregulated upon acquisition of anchorage-independent growth, and Table 2 lists the 54 upregulated genes. The most dramatic reductions in expression (20-fold) included regulatory genes such as E-cadherin and annexin 3. Smaller but significant changes (more than 5-fold) were observed with genes such as caveolin-1, which has known tumor suppressor activity [52, 53] . A wide range of genes was overexpressed in the anchorage-independent HMEC cells, the most prominent (60-fold) being CD36 (thrombospondin receptor).
Discussion
The purpose of this study was to investigate the impact of wt Myc and Myc phosphorylation deficient mutants (T58A, S62A and T58A/S62A) on post-selection HMECs. Specifically, we were interested in the potential differences in cellular immortalization and transformation among the various Myc constructs. While there is evidence suggesting that wt Myc can immortalize HMECs [16] , no studies have examined the efficiency of this process or the ability of phosphorylation deficient mutants to do so. Previous studies have shown that Myc phosphorylation status can affect cell transformation [29, 30, 33, 40, 41] . Yet for the most part, these studies were not conducted in human Genes shown have an absolute fold change of five or greater and a P-value \ 0.05 a Genes with more than one transcript (Fig. 1) . However, in one of the donors the HMECs transduced with wt Myc exhibited a growth lag compared to the Myc mutants, suggesting that wt Myc's ability to immortalize HMECs may vary from donor to donor. There is evidence that the immortalizing activity of wt Myc also may be celltype specific. Gil et al. found that Myc efficiently immortalized human prostate epithelial cells from two donors [54] . Yet we have observed that similar Myc overexpression was extremely toxic to human ectocervical cells and resulted in cell death (data not shown). These opposing effects of Myc overexpression in human epithelial cells from two different tissue types underscore the importance of studying Myc's effect on breast cells specifically.
Unlike other HMEC lines immortalized with a single oncogene, we found that the Myc T58A line and, to a lesser extent, the wt Myc line exhibited anchorage-independent growth (Fig. 5 ). This growth capability was accompanied by specific changes in cell morphology (Fig. 4) . None of the other HMEC immortalized cell lines formed colonies in soft agar. This capability was at least partially due to Myc, as evidenced by the induction of anchorage-independent growth in hTERT-immortalized HMECs by either wt Myc [18] (Fig. 6 ) or Myc T58A overexpression (Fig. 6) . However, growth for the wt Myc/hTERT line was not as robust as that reported previously [18, 55] . One possible explanation for this difference could be variations in the individual donor cells used in the studies. In addition, neither wt Myc/hTERT nor Myc T58A/hTERT HMECs exhibited the dramatic growth in soft agar as seen in Fig. 5 . This indicates that other molecular and/or genetic factors also played a role in this phenomenon. Hemann et al. reported that Myc T58A failed to upregulate the proapoptotic protein Bim, thus allowing cells to bypass apoptosis and become more oncogenic in a mouse model of lymphoma [42] . We did not see a similar pattern of Bim expression in our Myc T58A HMEC line (data not shown). However, we have seen that HMECs immortalized with Myc T58A are less sensitive to apoptotic stimuli than wt Myc HMECs (Fig. 2) . The observed decrease in apoptosis may be contributing to an increased capability for anchorage-independent growth in our system. The HMECs from this study provide a unique tool for indentifying the molecular and genetic changes during transition from the immortal to anchorage-independent states. To this end, we employed microarray analyses comparing Myc T58A HMECs pre-and post-anchorageindependent growth. The preliminary data generated from these assays (Tables 1 and 2 ) provide a good starting point for further research. In addition, given our results demonstrating a relationship between Myc T58A expression and anchorage-independent growth in breast cells, it will be important in the future to examine the phosphorylation status of Myc at T58 and/or Myc stability in breast cancer tissues. Genes shown have an absolute fold change of five or greater and a P-value \ 0.05 a Genes with more than one transcript
